唾液暗光褪黑素起始时间与早期肌萎缩侧索硬化功能衰退、呼吸症状出现及生存相关
该前瞻性纵向观察研究纳入50例症状出现18个月内的肌萎缩侧索硬化患者,通过家庭唾液褪黑素采样评估暗光褪黑素起始时间(DLMO)。患者DLMO较对照组提前,且基线DLMO较晚与功能状态较差、疾病进展更快、6个月时新发呼吸困难/端坐呼吸及生存/无气管切开结局较差相关;作者认为需更大独立队列验证其预后生物标志物价值。
要点
- 早期ALS患者唾液DLMO较年龄性别匹配对照提前(20:24±1:18 vs 20:58±0:50,p=0.028)。
- 基线DLMO较晚与6个月时新发呼吸困难/端坐呼吸相关(校正OR 3.11,p=0.019)。
- 基线DLMO较晚与功能/运动状态较差、疾病进展更快及生存/无气管切开结局较差相关。
核心结论
- 早期ALS可检测到昼夜节律相位改变,基线DLMO与功能、呼吸及生存结局存在探索性关联,需更大独立队列验证后才能视为经验证的预后生物标志物。
研究设计与样本
- 前瞻性纵向观察研究,纳入50例症状出现18个月内的肌萎缩侧索硬化患者,在习惯性睡眠起始前后6个预设时间点于暗光条件下进行家庭唾液褪黑素采样,并以年龄性别匹配对照进行褪黑素 profiling。
主要发现
- 与对照组相比,ALS患者DLMO提前(20:24±1:18 vs 20:58±0:50;p=0.028),而习惯性睡眠起始与 chronotype 相似。
- 在ALS队列内,基线DLMO较晚与功能/运动状态较差、疾病进展更快相关。
- 基线DLMO较晚与6个月时新发呼吸困难/端坐呼吸相关(校正OR 3.11;p=0.019)。
- 基线DLMO较晚与生存/无气管切开结局较差相关。
- 在重复采样亚组(n=28)中,DLMO及褪黑素衍生指标在约6个月内未发生变化。
关键数值与推荐
- DLMO定义为拟合曲线首次达到3 pg/ml的时间点。
- 褪黑素曲线采用三次平滑样条建模。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需更大独立队列验证后DLMO才能被视为经验证的预后生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective Sleep–wake and circadian disturbances are increasingly recognized in people living with amyotrophic lateral sclerosis (plwALS), but endogenous circadian phase timing and its prognostic significance in early disease remain unclear. We assessed whether salivary dim-light melatonin onset (DLMO), an objective marker of central circadian phase, is altered in early plwALS and whether it provides prognostic information. Methods In this prospective longitudinal observational study, plwALS within 18 months of symptom onset underwent home-based salivary melatonin sampling under dim-light conditions at 6 predefined time points around habitual sleep onset. Melatonin profiles were modeled using cubic smoothing splines, and DLMO was defined when the fitted curve first reached 3 pg/ml. Clinical, respiratory, and sleep assessments were collected at baseline (T0) and after 6 months (T6); a subgroup repeated saliva sampling at T6. Age- and sex-matched controls underwent melatonin profiling. Associations with disease progression, incident respiratory symptoms, and survival/tracheostomy were examined using regressions and survival analyses. Results A total of 50 plwALS were enrolled. Compared with controls, plwALS showed an earlier DLMO (20:24 ± 1:18 vs 20:58 ± 0:50; p = 0.028) despite similar habitual sleep onset and chronotype. Within ALS cohort, a later baseline DLMO correlated with worse functional/motor status, faster progression of disease, incident dyspnea/orthopnea by T6 (adjusted OR 3.11; p = 0.019), and poorer survival/tracheostomy-free outcome. In the resampled subgroup (n = 28), DLMO and melatonin-derived metrics did not change over ~6 months. Interpretation Circadian phase alterations are detectable in early ALS. Baseline DLMO showed exploratory associations with functional, respiratory, and survival outcomes. Larger independent cohorts are required before DLMO can be considered a validated prognostic biomarker. ANN NEUROL 2026
引用
- Annals of Neurology:Salivary Dim‐Light Melatonin Onset is Associated with Functional Decline, Respiratory Symptom Emergence, and Survival in Early Amyotrophic Lateral Sclerosis
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。